# US 2009/0270933 A1 · Pressure and Impedance Based Discrimination of Hemodynamic Stability

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270933 A1
- Document ID: US20090270933A1
- Status: Published application
- Kind: A1
- Application number: 12/108,785
- Filed: 2008-04-24
- Published: 2009-10-29
- Earliest claimed: 2008-04-24
- Assignees: Medtronic, Inc.
- Inventors: Douglas A. Hettrick; Kevin P. Vincent; Shantanu Sarkar; Yong-yo K.Y. Cho; Todd M. Zielinski
- Web page: https://patentgrep.com/patent/US20090270933A1

## CPC

- A61N 1/36585: {controlled by two or more physical parameters}
- A61B 5/0295: using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
- A61B 5/0538: invasively, e.g. using a catheter
- A61N 1/39622: {Pacing therapy}
- A61B 5/7264: {Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems}
- A61N 1/00: Electrotherapy; Circuits therefor (A61N2/00 takes precedence; irradiation apparatus A61N5/00)
- A61N 1/36521: {the parameter being derived from measurement of an electrical impedance}
- A61N 1/36564: {controlled by blood pressure}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An implantable cardioverter defibrillator evaluates the hemodynamic stability of an arrhythmia to determine whether or not to defibrillate. The device obtains cardiac pressure and cardiac impedance data and evaluates a phase relationship between these parameters. Hemodynamically stable rhythms will result in an out of phase relationship.

## Claims

### Claim 1

An implantable medical device (IMD) comprising:
a microprocessor configured to control operation of the IMD;
a pressure sensor coupled with the microprocessor and configured to provide ventricular pressure data to the microprocessor; and
an impedance sensor coupled with the microprocessor and configured to provide ventricular impedance data to the microprocessor, wherein the microprocessor is configured to determine hemodynamic stability based upon a phase relationship between the ventricular pressure data and the ventricular impedance data.

### Claim 2 (depends on 1)

The IMD of claim 1, further comprising a therapy delivery module operably coupled with the microprocessor, wherein the microprocessor causes the therapy delivery module to deliver a therapy based upon the determination of hemodynamic stability.

### Claim 3 (depends on 2)

The IMD of claim 2, wherein the microprocessor precludes the therapy deliver module from delivering a high power therapy if an arrhythmia is determined to be hemodynamically stable.

### Claim 4 (depends on 1)

The IMD of claim 1, wherein the pressure sensor is disposed on a right ventricular lead.

### Claim 5 (depends on 1)

The IMD of claim 1, wherein the pressure sensor is disposed on a left ventricular lead.

### Claim 6 (depends on 1)

The IMD of claim 1, wherein the pressure sensor is a left ventricular pressure sensor.

### Claim 7 (depends on 1)

The IMD of claim 1, wherein the impedance sensor includes a plurality of electrodes disposed along a single lead and configured to generate a constant current stimulation field.

### Claim 8 (depends on 1)

The IMD of claim 1, wherein the impedance sensor includes a right ventricular electrode and a left ventricular electrode.

### Claim 9 (depends on 1)

The IMD of claim 1, wherein the impedance sensor includes a right ventricular electrode and a can electrode.

### Claim 10

An implantable medical device comprising:
a microprocessor;
a therapy delivery module operably coupled with the module and configured to selectively deliver a defibrillation waveform or a pacing therapy in response to a cardiac arrhythmia;
a cardiac lead operably coupled with the microprocessor and the therapy delivery module and including one or more electrodes to provide the defibrillation waveform and the pacing therapy;
an impedance sensor communicatively coupled with the microprocessor to deliver ventricular impedance data, wherein at least a portion of the impedance sensor includes at least one of the one or more electrodes to sense impedance; and
a pressure sensor communicatively coupled with the microprocessor and configured to provide ventricular pressure data to the microprocessor, wherein the microprocessor is further configured to determine a phase relationship between the pressure data and the impedance data and to determine hemodynamic stability of a cardiac rhythm based upon the determined phase relationship.

### Claim 11 (depends on 10)

The IMD of claim 10, wherein the microprocessor precludes the therapy delivery module from delivering the defibrillation waveform unless the cardiac rhythm is hemodynamically unstable.

### Claim 12 (depends on 10)

The IMD of claim 10, wherein the microprocessor precludes the therapy delivery module from delivering the defibrillation waveform unless the cardiac rhythm is hemodynamically unstable or until a less aggressive therapy has proven unsuccessful if the cardiac rhythm is hemodynamically stable.

### Claim 13 (depends on 11)

The IMD of claim 11, wherein the pressure sensor is coupled with the cardiac lead.

### Claim 14 (depends on 11)

The IMD of claim 11, wherein the one or more electrodes includes a plurality of electrodes disposed along the cardiac lead and are configured to generate a constant current stimulation field.

### Claim 15

An implantable medical device (IMD) comprising:
means for sensing cardiac pressure;
means for sensing cardiac impedance; and
means for determining hemodynamic stability based upon a phase relationship between the sensed cardiac pressure and the sensed cardiac impedance.

### Claim 16 (depends on 15)

The IMD of claim 15, further comprising:
means for delivering therapy in response to the means for determining hemodynamic stability.

### Claim 17 (depends on 16)

The IMD of claim 16, wherein the means for delivering therapy are precluded from delivering a defibrillation waveform unless the cardiac rhythm is hemodynamically unstable.

### Claim 18 (depends on 15)

The IMD of claim 15, wherein the means for determining further include means for generating a phase plot between the sensed pressure and sensed impedance and determining a phase plot area.

### Claim 19 (depends on 18)

The IMD of claim 18, further comprising means for comparing the phase plot area to a baseline phase plot area to determine hemodynamic stability.
